Phase 2 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 75 years old
- People who are currently hospitalised in the surgical intensive care unit at Lariboisière Hospital after a brain bleed (subarachnoid haemorrhage) caused by a ruptured aneurysm
- People whose condition falls within a specific range of severity, based on two medical scoring systems called the WFNS score (levels I to IV) and the modified Fisher score (levels 3 or 4) — (confirm with trial site)
Who may not be able to join:
- Women who are pregnant
- People who have medical reasons why they cannot take the study drug, levosimendan — for example, an allergy to it, very low blood pressure, a very fast heart rate, or certain heart conditions that block normal blood flow
- People with severe kidney problems (where the kidneys are functioning at a low level, confirmed by a specific blood test result)
- People with severe liver failure or a long-term liver disease
- People who have previously had a specific type of dangerous heart rhythm problem called torsades de pointes
- People who already have serious pre-existing conditions affecting the blood vessels in the brain
- People who are considered to be at the very end of life
- People who are not registered with the French social security system
- People who are already taking part in another clinical trial that involves a treatment or intervention
- People who are under a legal protection order, such as guardianship or curatorship
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Benjamin Glen Chousterman, Hopital Lariboisière
Phone: 01.49.95.85.15
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
SAFETY / TOLERABILITY / EFFICACY; SAFETY / TOLERABILITY / EFFICACY
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.